Table 1 Demographic characteristics and clinical measurements of the included participants
Variables | Patients | HC (n = 25) | F/Z value | P value | |
---|---|---|---|---|---|
PDD (n = 24) | PDND (n = 24) | ||||
Age | 66.46 ± 8.19 | 64.50 ± 9.93 | 62.28 ± 6.88 | 3.24 | 0.198a |
Education | 11.71 ± 3.44 | 13.42 ± 2.64 | 12.32 ± 2.82 | 3.31 | 0.190a |
Gender (M/F) | 14/10 | 11/13 | 11/14 | 1.18 | 0.554b |
HAMA* | 10.71 ± 3.99 | 6.58 ± 3.22 | 3.00 ± 4.04 | 34.74 | 0.000a |
HAMD* | 16.08 ± 5.33 | 4.92 ± 1.91 | 4.04 ± 1.97 | 44.98 | 0.000a |
MADRS* | 12.46 ± 5.90 | 4.88 ± 3.27 | 2.84 ± 4.29 | 37.78 | 0.000a |
BDI* | 8.63 ± 3.44 | 3.58 ± 2.19 | 2.32 ± 3.42 | 37.29 | 0.000a |
UPDRS total* | 70.79 ± 26.83 | 47.71 ± 21.04 | NA | −3.02 | 0.003c |
UPDRS I* | 11.08 ± 3.84 | 6.67 ± 3.14 | NA | −3.62 | 0.000c |
UPDRS II* | 13.88 ± 6.26 | 8.71 ± 5.81 | NA | −2.89 | 0.004c |
UPDRS III* | 42.92 ± 17.92 | 30.92 ± 13.53 | NA | −2.47 | 0.014c |
UPDRS IV | 2.92 ± 3.79 | 1.42 ± 2.30 | NA | −1.00 | 0.316c |
H&Y stage* | 2.33 ± 0.67 | 1.89 ± 0.64 | NA | −2.23 | 0.026c |
MMSE | 28.38 ± 1.81 | 28.88 ± 1.23 | 28.24 ± 1.39 | 2.38 | 0.305a |